The programme will deploy GSK's meningococcal vaccine Bexsero (4CMenB), which was recommended by the UK's Joint Committee for Vaccination and Immunisation (JCVI) in 2023 in populations at high ...

The value of Bristol’s work came to the fore when the EU granted a license for the new Bexsero vaccine in 2013. The Joint Committee on Vaccination and Immunisation (JCVI), which advises the government ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

Trans amplifying mRNA vaccine expressing consensus spike elicits broad neutralization of SARS CoV 2 variants. npj Vaccines , 2025; 10 (1) DOI: 10.1038/s41541-025-01166-1 Cite This Page : ...

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax ...

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax ...

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School ...

Public health experts say Robert F. Kennedy Jr is exactly who they thought he was. The Health and Human Services (HHS) secretary — who is also the nation’s most well-known vaccine skeptic — i… ...

Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.